A PARADIGM SHIFT TO LONG-TERM OUTCOMES
We propose in this chapter a paradigm shift from a focus on short-term outcomes to long-term benefits after regional anesthesia. In the context of new models of healthcare delivery, 1 we discuss the clinical evidence favoring regional anesthesia for long-term patient-centered outcomes. 2 We define these as beneficial patient-centered outcomes that are the result of providing local or regional anesthesia and that persist for several months after the surgical intervention.
Bundled Capitated Payments Change the Way We Practice
Dramatic changes are underway to contain rising healthcare costs, which currently consume about one fifth of the gross domestic product of the United States. 1 In this changing healthcare system, anesthesiologists are confronted with a shift from fee-for-service to bundled capitated payments; anesthesia providers can no longer bill the insurance company directly for individual services. 3 Instead, lump payouts go to the institution. Providing additional services, such as a regional block, does not increase these capitated payments. The payments are to be shared between many providers including anesthesiologists, surgeons, internists, administrators, rehabilitation specialists, and nurses, all working under the same roof and competing for their fair share of the reimbursement. Regional anesthesia services require additional resources and training, and may work best in dedicated systems such as orthopedic hospitals or specialized ambulatory facilities. 4 However, we will increasingly have to justify to all stakeholders, even more than we do already, the additional manpower, resources, and time needed for regional anesthesia. Other stakeholders have their own interests. They include:
(1) Providers (surgeons) (2) Payers (inside and outside our institution) (3) Patients (and their relatives) (4) The public/regulators (especially Congress)
Beyond the well-researched and well-documented shortterm benefits of regional anesthesia, we need to convince everyone of the sustained and meaningful difference that extended perioperative nociceptive blockade can make in the lives of our patients long after surgery. To be effective patient advocates, we must support our arguments with the best available clinical evidence. 5 
Patient-centered Sustained Outcomes Will Dominate Resource Allocation
Abstract, population-based average effects or biomarkers as evidence of meaningful improvement in care are unconvincing in this day and age. Outcomes suitable as arguments for the sustained value of regional anesthesia should instead be patient centered. 2 Patient preferences, shared decision-making, and individualized tailored care are the hallmarks of this new paradigm in outcomes research, differentiating it from previous concepts of comparative effectiveness research. Much needs to be done to define and investigate patient-centered outcomes in anesthesiology and pain medicine, especially long-term outcomes. 6 Pay for performance is another emerging concept, forcing us to emphasize our unique contribution to the quality of patient outcomes. 7 What is the added value that anesthesiologists providing patients regional anesthesia contribute in the long run in the perioperative surgical home, where these anesthesiology subspecialists serve as the shepherds guiding the individualized perioperative recovery process?
Outcomes suitable as arguments for the sustained value of regional anesthesia should be patient centered.
Pain, Function, and Cognition as Cornerstones of Meaningful Long-term Recovery
In this chapter, we examine the clinical evidence suggesting that regional anesthesia has meaningful benefits for our patients and society beyond the immediate perioperative period. Although there are several other outcomes of interest, such as morbidity and mortality or cancer recurrence, we focus on three long-term outcomes after elective surgery based on their particular importance:
(1) Persistent pain (2) Joint function (3) Cognitive outcomes
We also selected these outcomes because their impact and significance are easy to convey to any interlocutor-surgical colleague, lay person, hospital administrator, or politicianregardless of their previous training or experience.
FOCUS 1: REGIONAL ANESTHESIA FOR THE PREVENTION OF PERSISTENT PAIN AFTER SURGERY

Case in Point
Your patient, an otherwise healthy 58-year-old woman, is about to undergo a right mastectomy for cancer. She is asking you what the respective benefits are of general and regional anesthesia. She is very adamant about being asleep and not knowing what happens during surgery, but seems open to the idea of an epidural or a paravertebral block to decrease the pain after surgery. What do you tell her? Impact Persistent pain (beyond 6 months after surgery) is a neglected, yet often severe and surprisingly frequent condition, as shown in Table 1 , which details the risk after several types of surgical intervention. There are few effective treatment options to date. 8 Prevention is therefore paramount (Supplemental Digital Content 1, http://links. lww.com/ASA/A567). Mild chronic pain can significantly diminish quality of life and impair daily functioning 10 ; intractable chronic pain can be devastating to both patient and family. Between 25 and 40% of patients undergoing thoracotomy, amputation, or breast surgery continue to suffer from persistent pain for months afterward. 11 Even for procedures with a lower risk of chronic post-surgical pain, such as hernia repair or cesarean section, prevention becomes important in light of their increasing frequency. 12 Approximately 5% of patients suffer from persistent pain after minor surgery and around 40% of patients after limb amputation or thoracotomy. 13 About 10% of patients develop persistent pain after a cesarean section. 12 Figure 1A shows the physiological transmission of pain from the primary nociceptor to the synapse in the dorsal horn of the spinal cord to the secondary neuron, which transmits the signal to the brain. During surgery, the barrage of nociceptive input from the surgical site induces central sensitization-a permanent increase in synaptic strength. These pathologic changes in synaptic transmission from the primary to the secondary neuron lead to perception of pain out of proportion to the stimulus ( Figure 1B) ; this is the physiological basis for the development of hyperalgesia (exaggerated perception of painful stimuli) and allodynia (painful perception of nonpainful stimuli, such as touch) and persistent pain after surgery. 14 An effective nociceptive block of regional anesthesia prevents pain impulses from being conducted from the surgical site to the central nervous system with subsequent sensitization, thus preventing the development of chronic pain ( Figure 1C ).
How This Intervention Might Work
Effects of the Intervention and Evidence Synthesis
A systematic review and metaanalysis for the Cochrane Collaboration found 23 randomized controlled trials (RCTs) investigating regional anesthesia or local anesthetics for the prevention of chronic pain after surgery. 15, 16 Pooled data from 250 patients in four RCTs with dichotomous outcomes at 6 months after thoracotomy strongly favored epidural anesthesia with an odds ratio of 0.34 and 95% confidence interval of 0.19-0.60. Data from 89 participants in two RCTs with outcomes at 5 or 6 months favored paravertebral block after breast cancer surgery with an odds ratio of 0.37 and 95% confidence interval of 0.14-0.94. Pooled results are shown in Figure 2 as forest plots. Including studies after cosmetic breast surgery and a study with multimodal topical analgesia increased the strength of the evidence. However, the conclusions were weakened by the intermediate methodological quality of the included studies.
Discussion of Included Studies and Their Limitations
We will discuss the individual studies and their strengths and weaknesses, stratifying them by surgical intervention. Studies and their designs are summarized in Table 2 .
Breast Surgery. Baudry et al. studied 81 patients undergoing breast cancer surgery and randomly assigned them to receive an infiltration with 40 mL of 4.75 mg/mL ropivacaine or 40 mL of saline at the end of the operation. 17 Fifty-three patients were interviewed by telephone 1 year postoperatively, and no difference was found in the rates of chronic pain evaluated using a French version of the McGill questionnaire (16 patients in the ropivacaine group vs. eight in the control group, P ¼ 0.19). Limitations included the following: patients undergoing both lumpectomy and mastectomy were included (although the proportions were similar in both groups); the intervention was a superficial wound infiltration rather than a nerve block or an epidural technique; it was performed at the end of the operation, thus not blocking painful stimuli from the surgical procedure; and the assessment was made by telephone rather than in a face-to-face interview.
Bell et al. 18 recruited 8 patients undergoing bilateral reduction mammoplasty. Patients were randomly assigned to have one breast infiltrated preoperatively with 100 mL of 5 mg/mL lidocaine and epinephrine, whereas the other was infiltrated with saline and epinephrine. Six months after surgery, patients were reassessed for spontaneous pain. Three patients reported ongoing periodic pain. For two, the pain was bilateral; however, one patient had undergone bilateral scar revision under local anesthesia shortly before the assessment. One patient reported pain localized ''deep'' in the lidocaine-treated breast. Issues include the small number of patients and the use of a shortacting local anesthetic. Ibarra et al. 19 randomly assigned 40 patients scheduled for radical mastectomy to general anesthesia with or without a paravertebral block, then assessed 29 patients by telephone 4 to 5 months later. Only five patients (33%) in the paravertebral block group reported chronic neuropathic pain, and none had phantom breast pain. In the group that received general anesthesia alone, one patient reported phantom breast pain, and six had neuropathic 15 
18
A t c h a b a h i a n a n d A n d r e a e pain, in two cases associated with phantom breast pain. The main limitations of this study were that breast-conserving operations were not included, despite evidence that those procedures lead to a higher rate of chronic pain, 26 and that a single-injection paravertebral block was used rather than injections at multiple levels.
Kairaluoma et al. 20 followed up 59 patients of 60 who had been randomly assigned to receive a preincisional paravertebral block using 1.5 mg/kg of 5 mg/mL bupivacaine at the third thoracic vertebra or a sham block using subcutaneous saline. After 1 year, five patients (16.7%) in the paravertebral block group still had pain, whereas 12 (40%) of those in the sham group had pain (P ¼ 0.008). The difference was still present when patients who had undergone an axillary dissection and those who had not were analyzed separately.
Fassoulaki et al. 21 randomly assigned 50 patients undergoing breast cancer surgery (lumpectomy or mastectomy) to receive a combination of gabapentin 400 mg every 6 hours for 8 days, 20 g of eutectic mixture of local anesthetic cream applied daily from the day of surgery until the third postoperative day, and an axillary brachial plexus block with 10 mL of 7.5 mg/mL ropivacaine as well as intercostal blocks with 3 mL of 7.5 mg/mL ropivacaine at the third, fourth, and fifth intercostal spaces, or a triple placebo. At 3 months, significantly fewer patients in the treatment group (10 of 22, 45%) than in the control group (18 of 22, 77%) had chronic pain. The difference (6 of 20 vs. 12 of 21) was not statistically significant at 6 months; however, the study was probably underpowered. One obvious confounder is that patients in the treatment group received gabapentin as well as regional analgesia, and thus the respective effects are impossible to tease out.
Thoracotomy (Supplemental Digital Content 2, http://links.lww.com/ASA/A568). Ju et al. 22 compared epidural analgesia with intercostal nerve cryoanalgesia in 107 patients undergoing thoracotomy. After 1 year, 16 of 38 patients (42.1%) in the epidural group had chronic pain versus 22 of 39 (56.4%) in the cryoanalgesia group (P ¼ 0.209), but three of 38 (7.9%) in the epidural group had pain that interfered with daily life versus 13 of 19 (33.3%) in the 15 Adaptations are themselves works protected by copyright. So in order to publish this adaptation, authorization must be obtained both from the owner of the copyright in the original work and from the owner of copyright in the translation or adaptation. cryoanalgesia group (P ¼ 0.014). Limitations included the use of cryoanalgesia rather than placebo, as cryoanalgesia might worsen neuropathic pain. Rather than performing an intentto-treat analysis, the authors withdrew seven patients from the study who had been assigned to the epidural arm but whose catheter was dislodged during the first two postoperative days. Also, the rate of chronic pain was not significantly different between groups; only the number of patients whose pain interfered with daily life activities reached significance.
Sentü rk et al. 23 compared three analgesic regimens after thoracotomy: bupivacaine and morphine epidural analgesia initiated before incision, bupivacaine and morphine epidural analgesia initiated postoperatively, and intravenous morphine patient-controlled analgesia (IV PCA). After 6 months, 18 of 23 (78%) IV PCA patients reported chronic pain versus 10 of 22 (46%) in the preoperative epidural group (P ¼ 0.023). No significant difference was found when the postoperative epidural group was compared with the other two groups. Of note, no patient reported that pain interfered with daily life activities.
Lu et al. 24 performed a similar study, randomly assigning 105 patients undergoing thoracotomy to one of three groups: ropivacaine and morphine epidurally, initiated either preoperatively or postoperatively, or intravenous fentanyl. After 6 months, significantly fewer patients had pain in the epidural groups than in the IV fentanyl group (P ¼ 0.010 and 0.003 for the groups receiving epidural analgesia initiated preoperatively and postoperatively, respectively). In this study, there did not seem to be a difference with epidural analgesia initiated before or after surgery.
Katz et al. 25 contacted patients from a previous study by telephone 18 months after their surgery. In that previous study, 27 they had randomly assigned 30 patients undergoing thoracotomy to receive either intercostal nerves with 3 mL of bupivacaine 5 mg/mL with epinephrine 1:200,000 at the level of the incision as well as two levels above and below, or saline placebo. The treatment group also received preoperative morphine, perphenazine (an antipsychotic), and indomethacin, whereas the control group received midazolam and a placebo. In the initial study, the treatment group used less morphine in the first 6 hours, but more on postoperative days 2 and 3. There was no difference in pain scores. At the latest follow-up, seven of 13 (53.8%) in the treatment group and five of 10 (50%) in the control group had evidence of chronic pain (P ¼ 1.000; data obtained from the authors and not included in the original publication). Issues with this study included the following: the small number of patients with large attrition by the last follow-up; the groups received a different pharmacological regimen besides the blocks with bupivacaine or saline; blocks were performed with general anesthesia and no effort was made to determine whether blockade was or was not successful; and there was no difference in pain scores initially (despite the differences in morphine use), and thus the discussed mechanism for the reduction of chronic pain could not have intervened. With a follow-up at 18 months-outside the predefined end point at 6 and 12 months-this study could not be pooled with the other three RCTs.
Summary. Evidence synthesis supports the use of epidural anesthesia for patients undergoing open thoracotomy, and paravertebral blocks for women undergoing breast cancer surgery, to reduce the risk of developing persistent pain 6 months after surgery. Persistent postsurgical pain may be devastating and resistant to treatment, but may be preventable in one patient of every four by an effective perioperative nociceptive blockade. It is remarkable how homogeneous and consistent the different RCTs, conducted in diverse settings, were in their estimates of the long-term effect. On a cautionary note, effects with specific regional blocks in one specific surgical intervention may not translate to other surgical procedures or regional anesthesia techniques (Supplemental Digital Content 3, http://links.lww.com/ASA/A569). You can tell your patient that perioperative regional anesthesia and analgesia likely reduces the risk of developing chronic pain after surgery. Outside the scope of this chapter, there is also evidence suggesting that avoiding general anesthesia and opioids, and using regional anesthesia and analgesia, can reduce the risk of cancer recurrence. 28 These are compelling arguments in favor of regional anesthesia in this case.
FOCUS 2: REGIONAL ANESTHESIA TO IMPROVE LONG-TERM FUNCTION AFTER MAJOR JOINT SURGERY
Case in Point
The chair of orthopedics at your hospital is asking your group to justify performing nerve blocks on his joint replacement patients. He wonders if it is worth the time and effort. He has the impression that his patients walk just as well after knee or hip replacement 3 months postoperatively regardless of whether or not they received a block. What do you answer?
Impact
With an aging population, severe pain or dysfunction of the major joints has become much more frequent, leading to higher numbers of total joint replacements (shoulder, hip, knee). Sustained improved flexibility and function, rather than immediate postoperative results, are the sought-after outcomes of these interventions; function and mobility define the activity and independence of our aging population and drive secondary comorbidities such as diabetes mellitus, obesity, and possibly even cognitive performance.
How This Intervention Might Work
Severe postoperative pain can hinder effective rehabilitation. Pain may lead to reflex inhibition of muscle fibers, limiting strength and muscle building. Optimal pain control enables patients to participate more actively in more forceful motion exercise. Single injection, continuous delivery through catheters, or sustained-release preparations of local anesthetics block the conduction of pain impulses from the operated joint to the central nervous system and may offer analgesia superior to that achieved with a combination of nonsteroidal antiinflammatory drugs, gabapentinoids, and opioids. Better pain control should allow more aggressive rehabilitation. 29 Early mobilization and range-of-motion exercises are probably the key factors in optimal long-term joint function-the outcome of interest. Early activity is associated with decreased adverse effects of immobilization on muscles and joints. 30 Rangeof-motion exercises facilitated by regional analgesia can increase passive knee flexion; these gains may be sustained for at least a few months after surgery 31 
Effects of the Intervention and Evidence Synthesis
We report and discuss the preliminary findings of our systematic review and metaanalysis for the Cochrane Collaboration, which is still unpublished and in the editorial phase. In Table 3 , we list eight RCTs reporting functional outcomes at or after 3 months following major joint replacement. Preliminary results, pooling data from 140 participants from three studies, suggest no significant improvement in range of motion (improvement of 41 with 95% confidence interval ranging from À2.23 to 10.21) (Supplemental Digital Content 5, http://links.lww.com/ASA/A571).
Discussion of Included Studies and Their Strengths and Weaknesses
Extended Regional Blocks Fail to Show Improved Long-term Function. Ilfeld et al. 39 examined the potential benefit of extending the duration of regional analgesia to several days postoperatively in both hip and knee replacement patients. An initial study was performed, enrolling patients undergoing total hip replacement or total knee replacement (TKR). 40 A continuous nerve block, lumbar plexus for hip patients and femoral for knee patients, was initiated preoperatively, and was continued for 24 hours with a subsequent saline infusion for patients in the control group or for 4 days for patients in the treatment group. The initial studies evaluated discharge readiness. Follow-up studies 32, 33 were performed 1 year after surgery to assess health-related quality of life using the WOMAC score (Western Ontario and McMaster Osteoarthritis Index) 41 and found no difference between groups. Significant attrition might have watered down any effect of regional anesthesia (total hip replacement: 47 patients enrolled and assessed at 1 year; TKR: 77 patients enrolled, 53 assessed at 1 year).
One can argue that, strictly speaking, these studies do not compare regional analgesia versus conventional analgesia, but rather two regimens of regional analgesia of different duration.
Regional Analgesia Versus Conventional Pain
Control Fails to Improve Outcomes at 6 Months.
Kadic et al. 34 examined 53 patients scheduled for TKR to see whether a continuous femoral nerve block improved function, assessing outcomes with the WOMAC score as well as the Knee Society Score. Although initially patients in the femoral nerve block group achieved better flexion 6 days after surgery, there was no difference in functional scores between groups at 3 months. Nader et al. 35 studied 62 patients undergoing TKR and receiving epidural analgesia until the first postoperative day. Upon removal of the epidural catheter, patients were randomly assigned to continuous femoral nerve blockade for 24 hours or oral analgesics. There was no difference in knee flexion after 6 or 12 months. WOMAC scores were not significantly different at 6 months and were significantly higher (worse outcome) in the continuous femoral nerve block group at 12 months. The authors attributed this result to the fact that this was a global function score and that more patients in the experimental group underwent further joint replacement procedures in the intervening year. As in Ilfeld's studies, all patients received regional analgesia for the first day and night.
Singelyn et al. 29 performed a three-arm study, randomly assigning 45 patients undergoing TKR under general anesthesia to receive, during the first 48 postoperative hours, either IV PCA with morphine, epidural analgesia, or continuous femoral nerve blockade (infusion of 1.25 mg/mL ropivacaine with sufentanil 0.1 mg/mL and clonidine 1 mg/ mL in both continuous regional analgesia groups). Postoperative pain scores were lower in the regional anesthesia groups than in the IV PCA group, and patients in the IV PCA group took significantly more days to achieve 901 flexion than those in the other groups. However, no difference was noted between groups after 3 months.
Tammachote et al. 36 randomly assigned 57 patients undergoing TKR under spinal anesthesia to one of two groups: intrathecal morphine (0.2 mg) or periarticular infiltration (100 mL containing 100 mg bupivacaine, 5 mg morphine, and 30 mg ketorolac). Patients then received a ketorolac IV PCA. There was no difference in the WO-MAC score or knee flexion after 3 months.
Wu and Wong 37 randomly assigned 60 patients undergoing TKR with spinal anesthesia to receive a continuous femoral nerve block (infusion continued until the third postoperative day) or no block. Patients received acetaminophen and diclofenac. Block patients received oral opioids as needed, whereas a morphine IV PCA was used in the other group. Knee Society Scores did not differ between the groups postoperatively or at 6 weeks, 3 months, or 6 months postoperatively. This study had a high rate of selection bias in that 79 patients were effectively enrolled, but 19 were excluded after entering the study because of technical problems or medical complications.
Zhang et al. 38 performed a three-arm study, randomly assigning 80 patients undergoing TKR with general anesthesia to receive, during the first 48 postoperative hours, either single-injection periarticular infiltration, continuous periarticular infiltration, or placebo. Knee flexion at 90 days was significantly higher in the infiltration groups than in the control group, and in the continuous infiltration group compared with the single-injection group.
Summary. Although well-documented short-term improvements in function were not sustained in the long run (at least in the preliminary results from this metaanalysis), we should point out important limitations in the quality of evidence. The diversity of patients, interventions, and agents used renders evidence synthesis challenging and may lead to missing an effect if it is really there. Indeed, the studies might have been underpowered to detect a small but meaningful effect. Generally, the considerable heterogeneity in interventions used and the outcomes reported hindered evidence synthesis. No study detailed the rehabilitation protocol used, and one might wonder how these could be improved to maximize the benefit of regional blockade. There were no studies of long-term shoulder function and only one study of patients following hip replacement.
Thus, the jury is still out with regard to regional anesthesia for improved long-term function after total knee surgery. More research is needed, for example, on newer regional analgesia interventions such as the adductor canal block, and taking full advantage of the aggressive rehabilitation possible with the exquisite pain control only attainable with regional anesthesia.
At this time, beyond the humane concept that even shortlived severe suffering is worth alleviating and the fact that acute pain is an important determinant of Press Ganey scores for the orthopedic department (and hence the public perception of its surgical performance), there is insufficient evidence to convince the chair of orthopedics that nerve blocks are leading to sustainable, demonstrable functional improvement for joint replacement patients beyond the immediate perioperative period. A caveat: this might be a case of absence of evidence rather than evidence of absence; the small number of studies and the subject attrition underline this argument. However, many orthopedic surgeons have been using periarticular infiltration, often with extendedrelease local anesthetics-thus in effect providing regional analgesia to their patients-without any convincing level 1 evidence of long-term benefits, to our knowledge. 
FOCUS 3: REGIONAL ANESTHESIA FOR IMPROVED COGNITIVE OUTCOMES AFTER NONCARDIAC SURGERY
Case in Point
An 80-year-old patient presents for total hip replacement. Airway concerns discourage you from using a spinal anesthetic with sedation and the patient in the lateral position. You suggest to the patient that general anesthesia might be a safer option. He tells you that his brother-in-law had general anesthesia recently and ''has not been the same since then.'' He is worried about how general anesthesia might impact his cognitive function, and asks whether regional anesthesia would be safer from that point of view. What do you tell him?
Impact
Long-term cognitive outcomes are very important to an increasingly elderly surgical population; postoperative cognitive dysfunction (POCD) impacts quality of life and independence of the elderly after surgery while often negating the success of the surgical intervention. 42 Three months after surgery, POCD 43 may be present in one of 10 high-risk (elderly) patients. 44 POCD and delirium independently predict other long-term outcomes such as increased morbidity and mortality, higher associated healthcare costs, long-term cognitive impairment, and further decline beyond 12 months. 45 
How This Intervention Might Work
The etiology of POCD after surgery is unclear. 42 Perioperative imbalances of neurotransmitter and inflammatory mediators have been implicated. Microemboli are a concern in orthopedic and cardiac surgery. Regional anesthesia may improve cognitive outcomes after surgery by attenuating the inflammatory response. The administration of benzodiazepines, opioids, and other psychotropic medications is associated with POCD and may trigger a vicious cycle of POCD leading to more medication leading to more POCD. Regional anesthesia, by controlling pain and obviating the need for opioids, may improve cognitive outcomes, but it is unclear whether these mechanisms lead to sustained improvement over conventional anesthetic approaches.
Effects of the Intervention and Evidence Synthesis
Whereas some systematic reviews of short-term cognitive outcomes suggest a clear benefit of regional anesthesia in the elderly, 46 others do not. 47, 48 Individual studies, summarized in Table 4 , do not support the hypothesis that regional anesthesia versus general anesthesia or regional analgesia versus conventional analgesia improves long-term cognitive function after surgery. A metaanalysis 55 of 26 RCTs with a total of more than 1,100 patients in each group (combining both long-term and short-term studies) failed to support the concern that general anesthesia contributed to long-term POCD in adults (standardized difference in means À0.08; 95% confidence interval À0.17 to 0.01; P ¼ 0.094) (Supplemental Digital Content 6, http://links.lww.com/ASA/A572). Some might question whether pooling the plethora of cognitive outcome measurements and patient population is meaningful.
Discussion of the Few Randomized Trials With Long-term Outcomes
We will discuss the few randomized controlled clinical trials with long-term cognitive outcomes comparing a regional anesthesia intervention versus a conventional general anesthesia approach; these RCTs are tabulated in Table 4 .
Jones et al. 49 randomly assigned 146 patients above 60 years of age and scheduled to undergo TKR or total hip replacement to general or spinal anesthesia and followed them up for 90 days. Cognitive and functional competence in these elderly patients was not detectably impaired after either general or regional anesthesia when attention was paid to the known perioperative influences on mental function.
Nielson et al. 50 included 98 individuals aged between 60 and 86 undergoing TKR and randomly assigned them to general or spinal anesthesia. There were no cognitive or psychosocial effects of general or regional anesthesia after 3 months.
Bigler et al. 51 studied 40 patients above 60 years of age about to undergo surgery for hip fracture and randomly assigned them to receive either general or spinal anesthesia. There were no significant cognitive differences between the two groups at any time up to the last follow-up at 90 days.
Williams-Russo et al. 52 enrolled 262 patients older than 40 (median age, 69 y) undergoing TKR and randomly assigned them to receive epidural anesthesia (followed in more than 95% of the cases by epidural analgesia) or general anesthesia (followed by IV PCA). There was a generalized pattern of decline at 1 week, followed at 6 months by either a return to baseline levels or improvement, but there were no significant differences between the groups in within-subject change from baseline on any of the 10 cognitive test results at either 1 week or 6 months.
Rasmussen et al., 53 in a multicenter trial involving 12 hospitals in seven countries, randomly allocated 428 patients aged 60 years or higher and undergoing major noncardiac surgery to regional anesthesia (spinal or epidural anesthesia; postoperative epidural analgesia was encouraged) or general anesthesia. No significant difference was found in the incidence of cognitive dysfunction after 3 months.
Campbell et al. 54 randomized 169 patients aged 65 to 98 years and undergoing cataract surgery to receive general or regional anesthesia. No evidence of long-term POCD was detected, and there was no significant difference in performance between the two groups up to the longest follow-up of 18 months.
Although there is evidence that short-term cognitive impairment might be more likely after general rather than regional anesthesia, you can reassure your patients that long-term differential effects have not been convincingly demonstrated. Summary. We caution thatour conclusions are based mostly on older small studies (in Guay's review, 55 18 of 26 studies date to 1995 or earlier) with significant attrition, whereas most recent RCTs did not follow up patients long enough to assess long-term cognitive outcomes. Patients with worse POCD may have selectively dropped out to avoid the embarrassment of failure in cognitive tests, biasing the studies toward the null hypothesis. Many patients in the regional anesthesia groups received midazolam, which may offset the potential benefit of regional anesthesia. 56 Most importantly, the focus of these studies was on intraoperative management, not on extended postoperative regional analgesia, where opioid sparing might have the strongest effect in preventing cognitive dysfunction.
Thus, although there is evidence that short-term cognitive impairment might be more likely after general rather than regional anesthesia, you can reassure your patient that long-term differential effects have not been demonstrated. Especially in elderly patients preferring regional anesthesia when the procedure is amenable to it and there are no medical contraindications, a regional technique is reasonable, and an excellent perioperative nociceptive regional anesthetic may avoid pain and the confusion sometimes induced by opioids in the elderly.
CONCLUSIONS
In our changing healthcare system, we need to convince patients, payers, providers, and the public that regional anesthesia is worth the resources invested. Indicating its obvious immediate benefits right after surgery may not be sufficient. We need to validate its sustained effects on longterm outcomes, among them on chronic pain after surgery, long-term function after joint replacement, and sustained cognitive outcomes in the elderly. The effects of regional anesthesia for the prevention of persistent postsurgical pain are robust. They are supported by many RCTs and a Cochrane review, and are based on a well-described molecular mechanism. At this time, there is insufficient evidence for improvement of long-term function after major joint repair, but because the rationale seems compelling, further studies are warranted. The benefit of regional anesthesia for long-term cognitive outcomes is currently unclear, and no molecular or animal model offers a clear mechanism easily amenable to a regional anesthesia intervention.
To ensure that the benefits of regional anesthesia will remain available to our patients, the regional anesthesia community should focus research and development on sustained benefits of patient-centered extended perioperative nociceptive blockade and engage itself deeply in the rehabilitation effort.
